Healthcare - Biotechnology - NASDAQ - US
$ 8.5
-3.74 %
$ 600 M
Market Cap
-4.83
P/E
BALANCE SHEET
252 M
ASSETS
27.9 M
LIABILITIES
224 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
ORIC Pharmaceuticals, Inc.
| Current Assets | 213 M |
| Cash & Short-Term Investments | 208 M |
| Receivables | 0 |
| Other Current Assets | 4.41 M |
| Non-Current Assets | 39.4 M |
| Long-Term Investments | 26.9 M |
| PP&E | 12 M |
| Other Non-Current Assets | 552 K |
| Current Liabilities | 20.5 M |
| Accounts Payable | 944 K |
| Short-Term Debt | 2.75 M |
| Other Current Liabilities | 16.8 M |
| Non-Current Liabilities | 7.46 M |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 7.46 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 23.4 | 66.8 | 226.0 | 78.4 | 89.2 | 42.6 | 25.8 |
| Short Term Investments | 184.8 | 139.4 | 11.0 | 215.2 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 4.4 | 4.2 | 7.1 | 6.2 | 0.8 | 1.1 | 0.8 |
| Total Current Assets | 212.6 | 210.5 | 240.5 | 296.7 | 90.0 | 43.7 | 26.6 |
| PP&E | 12.0 | 3.3 | 2.4 | 2.0 | 2.2 | 2.5 | 2.9 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 26.9 | 22.0 | 43.4 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0.6 | 11.5 | 12.3 | 0.3 | 1.9 | 0.5 | 0.5 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Total Assets | 252.0 | 247.2 | 298.6 | 299.0 | 94.1 | 46.7 | 30.0 |
| LIABILITIES | |||||||
| Accounts Payable | 0.9 | 1.3 | 1.9 | 0.8 | 0.2 | 0.4 | 0.9 |
| Short Term Debt | 2.8 | 2.7 | 1.9 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 16.8 | 11.4 | 11.3 | 8.2 | 4.7 | 1.7 | 1.3 |
| Total Current Liabilities | 20.5 | 15.4 | 15.2 | 9.0 | 5.4 | 2.6 | 2.6 |
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 3.2 | 3.4 | 0 | 0 | 0 | 0 |
| Other Liabilities | 7.5 | 9.4 | 10.5 | 0.2 | 0 | 107.3 | 0 |
| Total Liabilities | 27.9 | 24.8 | 25.7 | 9.2 | 6.1 | 111.2 | 4.3 |
| EQUITY | |||||||
| Common Stock | 6 K | 5 K | 4 K | 4 K | 2 K | 1 K | 1 K |
| Retained Earnings | (434.9) | (334.2) | (245.1) | (166.4) | (92.7) | (65.8) | (44.4) |
| Other Accumulative Comprehensive Income/Loss | 0.3 | (1.3) | (0.1) | 31 K | (178.1) | (2.6) | 0 |
| Total Equity | 224.1 | 222.4 | 273.0 | 289.8 | 88.0 | (64.4) | 25.7 |
| Total Liabilities and Equity | 252.0 | 247.2 | 298.6 | 299.0 | 94.1 | 46.7 | 30.0 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 51.5 | 39.7 | 38.0 | 21.9 | 29.9 | 19.1 | 29.9 |